Day: February 20, 2026

NANO Nuclear Expands its Nuclear Policy Leadership Expertise with the Appointment of U.S. Government Veteran Sarah Lennon as its International Nuclear Policy Advisor

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Figure 1NANO Nuclear Appoints Experienced DOE and NNSA Professional Sarah Lennon as its International Nuclear Policy Advisor.New York, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced the appointment of Sarah Lennon as its International Nuclear Policy Advisor. Sarah is a seasoned national security and nuclear energy policy leader with three decades of distinguished service across the U.S. Government, bringing deep expertise in nuclear security, nonproliferation, international cooperation, and strategic planning. “It is a pleasure to join the NANO Nuclear team,” said Sarah Lennon, International Nuclear Policy Advisor of...

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Enables Potential Shorter Time to Accelerated Approval of PDS0101 in HPV16-positive Head and Neck Cancer PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced the adoption of a protocol amendment to its Phase 3 VERSATILE-003 clinical trial. The amendment includes PFS as an interim primary endpoint to support a potential accelerated approval pathway for PDS0101 in HPV16-positive recurrent and/or metastatic head and neck cancer. Median overall survival (mOS) remains the trial’s primary endpoint for full approval, consistent with the Company’s prior regulatory dialogue and post-meeting communication following its Type C meeting with the...

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2025 after the close of trading on Wednesday, March 4, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/. About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, LungTraX™ Platform,...

National Healthcare Properties Reports Fourth Quarter and Full Year 2025 Results

Written by Customer Service on February 20, 2026. Posted in Earnings Releases And Operating Results.

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on senior housing and outpatient medical facilities, today announced results for the fourth quarter and full year ended December 31, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the exceptional internal growth of our senior housing portfolio and the steady performance of our outpatient medical portfolio in 2025. We believe the fundamentals within the healthcare real estate industry, especially the senior housing sector, remain robust. We are excited about the year ahead and are committed to delivering strong performance across our business.” Financial Performance and Other Highlights Fourth...

Digital Currency X Technology Inc. Regains Compliance with Nasdaq Bid Price Requirement and Hearing Cancelled

Written by Customer Service on February 20, 2026. Posted in Public Companies.

New York, Feb. 20, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (Nasdaq: DCX) (the “Company”), a pioneering digital asset treasury management company, today announced that it received a written notification from The Nasdaq Stock Market LLC, dated February 17, 2026, confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and is therefore in full compliance with all applicable Nasdaq Capital Market listing requirements. As a result, the previously scheduled hearing before the Hearings Panel on February 24, 2026 has been canceled. The Company’s securities will continue to be listed and traded on the Nasdaq Capital Market without interruption. About Digital Currency X Technology Inc. Digital Currency X Technology Inc. (NASDAQ: DCX) is a pioneering...

No. 1/2026 – Financial calendar 2026/2027

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Nasdaq Copenhagen Nikolaj Plads 6DK-1067 Copenhagen K Copenhagen, 20 February 2026ANNOUNCEMENT no. 1/2026 FINANCIAL CALENDAR 2026/2027 The financial calendar for 2026/2027 has been scheduled as follows: 2026: 25.02.2026 Annual Report 2025 24.03.2026 Annual General Meeting 26.08.2026 Interim Report, H1 2026 2027: 23.02.2027 Annual Report 2026 18.03.2027 Annual General MeetingCemat A/S Frede ClausenChairman of the BoardThis announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no. 1 – 20.02.2026 – Financial calendar

MARA Schedules Conference Call for Fourth Quarter and Fiscal Year 2025 Financial Results

Written by Customer Service on February 20, 2026. Posted in Public Companies.

Earnings Webcast and Conference Call Set for Thursday, February 26, 2026 at 5:00 p.m. ET Miami, FL, Feb. 20, 2026 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a leading digital energy and infrastructure company, will hold a webcast and conference call on Thursday, February 26, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the quarter and fiscal year ended December 31, 2025. Financial results will be published in a shareholder letter prior to the call on the investor relations section of the Company’s website. To register to participate in the conference call or to listen to the live audio webcast, please use this link. The webcast will also be broadcast live and available for replay via the investor relations section of the Company’s website. Earnings...

NEXE Innovations Ships 315,000 BPI-Certified Compostable Coffee Pods Year‑to‑Date and Introduces 8 New SKUs

Written by Customer Service on February 20, 2026. Posted in Public Companies.

WINDSOR, Ontario, Feb. 20, 2026 (GLOBE NEWSWIRE) — NEXE Innovations Inc. (“NEXE”, the “Company”, “we”, “us” or “our”) (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce it has shipped 315,000 BPI-certified compostable coffee pods year-to-date to two existing customers, reflecting accelerating repeat demand and SKU expansion. The orders were fulfilled for ecoBeans Coffee and a North American office coffee services (OCS) distributor, reinforcing NEXE’s growing footprint in both retail and commercial channels. The shipments included 20 SKUs, of which 8 were newly introduced products, demonstrating product line expansion and deeper customer penetration. After demonstrating commercial success through targeted...

FTC Solar to Announce Fourth Quarter and Full Year 2025 Financial Results Thursday, March 5, 2026

Written by Customer Service on February 20, 2026. Posted in Public Companies.

AUSTIN, Texas, Feb. 20, 2026 (GLOBE NEWSWIRE) — FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its fourth quarter and full year 2025 financial results before market open on Thursday, March 5, 2026. A conference call for members of the investment community will be held at 8:30 a.m. E.T. that same day, during which the Company will discuss its fourth quarter and full year 2025 results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of the FTC Solar corporate website at investor.ftcsolar.com. A replay of the conference call will also be available on the website for 30 days following the webcast. About FTC Solar, Inc.Founded in 2017 by a group of renewable energy...

Nasus Pharma to Participate in Upcoming Investor Conferences

Written by Customer Service on February 20, 2026. Posted in Public Companies.

TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate and time: February 25, 2026, 1:20 p.m. ET Location: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/KoYPJS8x3zqMuXPHfEHoSY) Format: Company presentation Speaker: Dan Teleman, Chief Executive OfficerBIO Investment & Growth SummitDate and time: March 2, 2026, 10:15 a.m. ET Location: Miami, FL Format: Company presentation Speaker: Dan Teleman, Chief Executive OfficerCitizens Life...

Day: February 20, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals